Adhera Therapeutics to Collaborate with Alberta Diabetes : c

Data will be instrumental in upcoming Phase 2 clinical trial of MLR-1023, Adhera’s novel Type 1 Diabetes drug candidateCompany moving forward with...

Related Keywords

Canada , Zahed Subhan , Jean Buteau , Andrew Kucharchuk , Exchange Commission , University Of Alberta , Alberta Diabetes Institute Is Canada , Adhera Therapeutics Inc , Alberta Diabetes Institute , Nasdaq , Edmonton Protocol , Chief Executive Officer , Chief Operating Officer , Typei Diabetes , Non Alcoholic Steatohepatitis , Familial Adenomatous Polyposis , Private Securities Litigation Reform Act , Adhera Therapeutic , Adhera Therapeutics , Other Otc Atrx , Nc , Tcqb Atrx , Ollaborate , Initiate Clinical Trial ,